Aura Biosciences, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2018-12-13: Federal exemption Rule 506(b); Types of securities offered Equity; SecurityToBeAcquired; Date of first sale 2017-12-20; Total offering amount $42,470,393.
- 2018-01-03: Federal exemption Rule 506(b); Types of securities offered Equity; SecurityToBeAcquired; Date of first sale 2017-12-20; Total offering amount $42,272,525.
- 2017-11-02: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2016-09-15; Total offering amount $11,537,655.
- 2016-09-30: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2016-09-15; Total offering amount $8,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2018-12-13 D/A | Rule 506(b) | Equity; SecurityToBeAcquired | 2017-12-20 | $42,470,393 | $42,272,525 | $197,868 | 42 |
| 2018-01-03 | Rule 506(b) | Equity; SecurityToBeAcquired | 2017-12-20 | $42,272,525 | $32,441,478 | $9,831,047 | 42 |
| 2017-11-02 D/A | Rule 506(b) | Debt; OptionToAcquire; SecurityToBeAcquired | 2016-09-15 | $11,537,655 | $11,537,655 | $0 | 38 |
| 2016-09-30 | Rule 506(b) | Debt; OptionToAcquire; SecurityToBeAcquired | 2016-09-15 | $8,000,000 | $1,812,166 | $6,187,834 | 27 |
| 2015-03-05 | Rule 506(c) | Equity; OptionToAcquire | 2015-02-24 | $34,500,000 | $21,017,623 | $13,482,377 | 21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |